Precipio, Inc.
Market Cap
$49.68M
P/E Ratio
-35.01
EPS
$-0.81
Dividend Yield
0.00%
52-Week Range
$3.90 — $29.53
Volume
38
Avg Volume
14.40K
Beta
1.25
P/E (TTM)
-35.01
Forward P/E
1.03
PEG Ratio
-1.15
P/S (TTM)
2.19
P/B (TTM)
3.20
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.10%
ROA (TTM)
-0.06%
ROIC
—
Gross Margin
0.47%
Operating Margin
-0.10%
Net Margin
—
Debt/Equity
0.26
Current Ratio
1.27
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.20%
EPS Growth (5Y)
+0.35%
Sales Growth (3Y)
+0.24%
Sales Growth (5Y)
+0.43%
EPS Est (This Year)
$27.40
EPS Est (Next Year)
—
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$1.41
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
40
Outstanding Shares
1.75M
Float
1.42M
Free Float %
81.28%
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
US
Exchange
NASDAQ
IPO Date
2017-06-30
Employees
54
CEO
Ilan Danieli
Index Membership
—
Website
https://www.precipiodx.com
Precipio, Inc. (PRPO) is a healthcare company in the medical - diagnostics & research industry listed on the NASDAQ. With a market capitalization of $49.68M, a P/E ratio of -35.01, PRPO is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare PRPO against other stocks using dozens of fundamental and technical filters.
Precipio, Inc. (PRPO) has a trailing twelve-month (TTM) P/E ratio of -35.01. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Precipio, Inc. (PRPO) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Precipio, Inc. (PRPO) has a market capitalization of $49.68 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.